RETA Stock Soars 157% in a Month: Are You Excited?
RETA stock has soared over 155% over the past month on multiple news from Reata Pharmaceuticals Inc (NASDAQ:RETA).
Many pharmaceutical stocks have enjoyed significant gains this year, but there are very few stocks …
BGNE Stock Soars After Amgen Invests $2.7B in BeiGene
BGNE stock is on roll after Amgen Inc. (NASDAQ:AMGN) announced that it is investing around $2.7 billion in Chinese biotech company BeiGene Ltd (NASDAQ:BGNE). The company will take a 20.5% stake in the drug developer. …
ACAD Stock Hits Multi-Year Highs on Impressive Data
ACAD stock is the biggest biotech stock gainer in Monday’s session after ACADIA Pharmaceuticals (NASDAQ:ACAD) announced successful results in its Phase 3 clinical trial of HARMONY.
Big Relief for Investors
When a pharmaceutical …
ACAD Stock Slumps to 5-Month Low on Schizophrenia Setback
ACAD stock is taking a major hit today, slumping to a new 5-month low after Acadia Pharmaceuticals Inc (NASDAQ:ACAD)’s schizophrenia treatment did not pass a late-stage clinical trial.
Clinical trials are …
AMRN Stock Rockets 13% As Amarin Sees Strong Revenues
AMRN has been on a tear on Tuesday and has gone up by as much as 13% as Amarin Corporation plc (NASDAQ:AMRN) raised its projections for the company’s revenues for the year 2019.
Revenue … Read
ARRY Stock Hits All-Time High on Pfizer’s Acquisition
ARRY stock is witnessing a solid day after Pfizer Inc (NYSE:PFE) announced it was acquiring Array Biopharma Inc (NASDAQ:ARRY).
62% Premium on ARRY Stock
In a significant development, pharmaceutical giant Pfizer has decided …
Advaxis Shares Pop Up 72% On Solid Data For ADXS-NEO
Shares of Advaxis (NASDAQ:ADXS) are up a whopping 72%, selling for $10.20 this morning after the company released improved data for its personalized cancer vaccine candidate ADXS-NEO.
The stock is up about 32% …
Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%
Biogen Alzheimer’s Drug Trial: Finding a cure for Alzheimer’s disease can look like an impossible mission, even for the most brilliant minds. What isn’t impossible, however, is offering disease-modifying therapies to those suffering from the …
Auris Health – Monarch Platform Will Revolutionize Medical Intervention
Silicon Valley-based Auris Health Inc., formerly Auris Surgical Robotics Inc., announced that the company’s Monarch Platform has received clearance from the US Food and Drug Administration.
The platform received clearance for diagnostic and …
Spark Therapeutics Shares Plunged More Than 40% Today, Here’s Why
On Monday, in early trade, Spark Therapeutics, Inc. (NASDAQ:ONCE) saw its shares plunge more than 40%.
What happened? Well, the decline started after the gene therapy biotech company disclosed data from various trials …